Your browser doesn't support javascript.
loading
A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.
Schneemann, Anette; Speir, Jeffrey A; Tan, Gene S; Khayat, Reza; Ekiert, Damian C; Matsuoka, Yumiko; Wilson, Ian A.
Afiliação
  • Schneemann A; Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.
J Virol ; 86(21): 11686-97, 2012 Nov.
Article em En | MEDLINE | ID: mdl-22896619
ABSTRACT
The discovery of broadly neutralizing antibodies that recognize highly conserved epitopes in the membrane-proximal region of influenza virus hemagglutinin (HA) has revitalized efforts to develop a universal influenza virus vaccine. This effort will likely require novel immunogens that contain these epitopes but lack the variable and immunodominant epitopes located in the globular head of HA. As a first step toward developing such an immunogen, we investigated whether the 20-residue A-helix of the HA2 chain that forms the major component of the epitope of broadly neutralizing antibodies CR6261, F10, and others is sufficient by itself to elicit antibodies with similarly broad antiviral activity. Here, we report the multivalent display of the A-helix on icosahedral virus-like particles (VLPs) derived from the capsid of Flock House virus. Mice immunized with VLPs displaying 180 copies/particle of the A-helix produced antibodies that recognized trimeric HA and the elicited antibodies had binding characteristics similar to those of CR6261 and F10 they recognized multiple HA subtypes from group 1 but not from group 2. However, the anti-A-helix antibodies did not neutralize influenza virus. These results indicate that further engineering of the transplanted peptide is required and that display of additional regions of the epitope may be necessary to achieve protection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Glicoproteínas de Hemaglutininação de Vírus da Influenza / Reações Cruzadas / Anticorpos Antivirais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Glicoproteínas de Hemaglutininação de Vírus da Influenza / Reações Cruzadas / Anticorpos Antivirais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2012 Tipo de documento: Article